blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1781210

EP1781210 - COMPOSITE VASCULAR GRAFT INCLUDING BIOACTIVE AGENT COATING AND BIODEGRADABLE SHEATH [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.11.2013
Database last updated on 25.09.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Boston Scientific Limited
P.O. Box 1317 Seaston House Hastings Christ Church
Barbados, West Indies / BB
[2009/47]
Former [2007/19]For all designated states
Boston Scientific Scimed, Inc.
One Scimed Place
Maple Grove, MN 55311 / US
Inventor(s)01 / MI LYN TAN, Sharon
9 High Rock Way
Allston, MA 02134 / US
 [2007/19]
Representative(s)Intès, Didier Gérard André, et al
Cabinet Beau de Loménie
158 rue de l'Université
75340 Paris Cedex 07 / FR
[N/P]
Former [2013/03]Intès, Didier Gérard André, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cedex 07 / FR
Former [2009/47]Intes, Didier Gérard André, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cedex 07 / FR
Former [2008/37]Intes, Didier Gérard André
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cedex 07 / FR
Former [2007/19]Peel, James Peter
Barker Brettell, 10-12 Priests Bridge
London SW15 5JE / GB
Application number, filing date05789032.911.07.2005
[2007/19]
WO2005US24418
Priority number, dateUS2004088943212.07.2004         Original published format: US 889432
[2007/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006017204
Date:16.02.2006
Language:EN
[2006/07]
Type: A1 Application with search report 
No.:EP1781210
Date:09.05.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 16.02.2006 takes the place of the publication of the European patent application.
[2007/19]
Type: B1 Patent specification 
No.:EP1781210
Date:16.01.2013
Language:EN
[2013/03]
Search report(s)International search report - published on:EP16.02.2006
ClassificationIPC:A61F2/06
[2007/19]
CPC:
A61F2/06 (EP,US); A61F2/07 (EP,US); A61F2002/072 (EP,US);
A61F2210/0004 (EP,US); A61F2250/0067 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/19]
TitleGerman:VERBUNDGEFÄSSIMPLANTAT MIT BIOAKTIVER WIRKSTOFFBESCHICHTUNG UND BIOLOGISCH ABBAUBARER HÜLLE[2012/28]
English:COMPOSITE VASCULAR GRAFT INCLUDING BIOACTIVE AGENT COATING AND BIODEGRADABLE SHEATH[2007/19]
French:GREFFE VASCULAIRE COMPOSITE COMPRENANT UN REVETEMENT D'AGENT BIOACTIF ET UNE GAINE BIODEGRADABLE[2007/19]
Former [2007/19]VERBUNDGEFÄSSIMPLANTAT MIT BIOAKTIVER WIRKSTOFFBESCHICHTUNG UND BIOLOGISCH ABBAUBARER SCHLEUSE
Entry into regional phase12.02.2007National basic fee paid 
12.02.2007Designation fee(s) paid 
12.02.2007Examination fee paid 
Examination procedure12.02.2007Examination requested  [2007/19]
26.01.2010Despatch of a communication from the examining division (Time limit: M06)
22.06.2010Reply to a communication from the examining division
26.07.2012Communication of intention to grant the patent
03.12.2012Fee for grant paid
03.12.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.01.2010
Opposition(s)17.10.2013No opposition filed within time limit [2013/52]
Fees paidRenewal fee
04.07.2007Renewal fee patent year 03
27.03.2008Renewal fee patent year 04
08.07.2009Renewal fee patent year 05
08.07.2010Renewal fee patent year 06
16.07.2011Renewal fee patent year 07
13.07.2012Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.07.2005
AT16.01.2013
BE16.01.2013
CY16.01.2013
CZ16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
TR16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
CH31.07.2013
LI31.07.2013
[2015/34]
Former [2015/32]AT16.01.2013
BE16.01.2013
CY16.01.2013
CZ16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
TR16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
CH31.07.2013
LI31.07.2013
Former [2015/30]AT16.01.2013
BE16.01.2013
CY16.01.2013
CZ16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
CH31.07.2013
LI31.07.2013
Former [2014/20]AT16.01.2013
BE16.01.2013
CZ16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
CH31.07.2013
LI31.07.2013
Former [2014/14]AT16.01.2013
BE16.01.2013
CZ16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2014/03]AT16.01.2013
BE16.01.2013
CZ16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/49]AT16.01.2013
BE16.01.2013
CZ16.01.2013
EE16.01.2013
FI16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/40]AT16.01.2013
BE16.01.2013
FI16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
SE16.01.2013
SI16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/38]AT16.01.2013
BE16.01.2013
FI16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
SE16.01.2013
SI16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
Former [2013/37]AT16.01.2013
BE16.01.2013
FI16.01.2013
LT16.01.2013
PL16.01.2013
SE16.01.2013
SI16.01.2013
BG16.04.2013
GR17.04.2013
IS16.05.2013
Former [2013/36]AT16.01.2013
BE16.01.2013
LT16.01.2013
PL16.01.2013
SE16.01.2013
BG16.04.2013
IS16.05.2013
Former [2013/35]BE16.01.2013
LT16.01.2013
SE16.01.2013
BG16.04.2013
IS16.05.2013
Former [2013/34]LT16.01.2013
SE16.01.2013
BG16.04.2013
IS16.05.2013
Former [2013/33]LT16.01.2013
Cited inInternational search[Y]WO9529647  (SCIMED LIFE SYSTEMS INC [US]) [Y] 7-9 * page 5, line 14 - line 15 *;
 [A]US6379382  (YANG JUN [US]) [A] 1-24* column 5, line 9 - line 23 *;
 [XY]WO02056790  (AVANTEC VASCULAR CORP [US], et al) [X] 1-5,10-24 * page 11, line 11 * * page 13, line 25 - line 27 * * page 32, line 25 - line 27 * * page 35, line 20 * * page 36, line 32 - page 37, line 9 * * figures 2d,2g,2k * [Y] 6-9;
 [XY]US2003060871  (HILL JASON PETER [US], et al) [X] 1 * paragraphs [0012] , [0027] - [0029] - [0034] * * figure 6 * * claim 37 * [Y] 6;
 [PA]US2004236415  (THOMAS RICHARD [US]) [PA] 1 * paragraph [0041] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.